Elevance Health
ELV
1,170 hedge funds and large institutions have $70.7B invested in Elevance Health in 2020 Q4 according to their latest regulatory filings, with 166 funds opening new positions, 376 increasing their positions, 426 reducing their positions, and 77 closing their positions.
116% more first-time investments, than exits
New positions opened: 166 | Existing positions closed: 77
18% more capital invested
Capital invested by funds: $59.8B → $70.7B (+$11B)
7% more funds holding
Funds holding: 1,094 → 1,170 (+76)
1.9% less ownership
Funds ownership: 90.48% → 88.58% (-1.9%)
12% less repeat investments, than reductions
Existing positions increased: 376 | Existing positions reduced: 426
17% less call options, than puts
Call options by funds: $477M | Put options by funds: $577M
19% less funds holding in top 10
Funds holding in top 10: 27 → 22 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Newport Trust Company
Washington,
District of Columbia
|
+$451M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$237M |
| 3 |
MWNA
Marshall Wace North America
New York
|
+$188M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$153M |
| 5 |
Sanders Capital
West Palm Beach,
Florida
|
+$117M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Optimal Asset Management
Los Altos,
California
|
-$681M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$531M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$233M |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$209M |
| 5 |
Capital International Investors
Los Angeles,
California
|
-$180M |
ELV Hedge Fund Activity: Q4 2020 in Review
1,170 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q4 2020, worth a combined $70.7B — up 18% from $59.8B a quarter earlier.
Buyers outnumbered sellers: 166 funds opened new ELV positions and 77 closed out — a net gain of 89 holders — while 376 added to existing stakes and 426 trimmed.
The largest buyer was Newport Trust Company, opening a new position worth an estimated $451M. The largest seller was Optimal Asset Management, cutting an estimated $681M.
- 1,170 institutional investors held Elevance Health (ELV) as of Q4 2020, up from 1,094 in Q3 2020.
- Funds reported $70.7B of Elevance Health stock for Q4 2020, up 18% quarter-over-quarter.
- 166 funds opened new Elevance Health positions in Q4 2020 and 77 closed out, a net change of +89 holders.
- The largest Elevance Health buyer in Q4 2020 was Newport Trust Company, an estimated $451M added.
- The largest Elevance Health seller in Q4 2020 was Optimal Asset Management, an estimated $681M sold.
Based on aggregated 13F filings for Q4 2020.